Pre-Hematopoietic Cell Transplant (HCT) Disease Status and Early Post-HCT Bone Marrow (BM) Chimerism Remain Predictors of Leukemia Relapse in Children Who Receive Preemptive Post-HCT Immunomodulatory Therapy (IT)

被引：0
|
作者：
Horn, Biljana [1 ]
Petrovic, Aleksandra [2 ]
Wahlstrom, Justin T. [1 ]
Dvorak, Christopher C. [3 ]
Kong, Denice [4 ]
Exposer-Spencer, Jueleah [5 ]
Cowan, Morton J. [1 ]
机构：
[1] UCSF Benioff Childrens Hosp, Pediat Allergy Immunol & Blood & Marrow Transplan, San Francisco, CA USA
[2] Univ S Florida, All Childrens Hosp, St Petersburg, FL 33701 USA
[3] Univ Calif San Francisco, Med Ctr, San Francisco, CA USA
[4] UCSF, San Francisco, CA USA
[5] UCSF, Benioff Childrens Hosp, San Francisco, CA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2014年 / 20卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2013.12.102
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
89
引用
收藏
页码：S82 / S83
页数：2
相关论文
共 4 条
  • [1] OUTCOMES OF CHILDREN WITH HEMATOLOGIC MALIGNANCIES WHO RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION AND POST-HCT MINIMAL RESIDUAL DISEASE
    Shah, Nirali
    Borowitz, Michael
    Robey, Nancy
    Gamper, Christopher
    Symons, Heather
    Loeb, David
    Wayne, Alan
    Chen, Allen
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S98 - S98
  • [2] Donor Hematopoietic Cell Telomere Length and Magnitude of Post-HCT Shortening Predict Survival in Early Stage Leukemia and Myelodysplastic Syndrome
    Gadalla, Shahinaz M.
    Katki, Hormuzd
    Lai, Tsung-Po
    Dagnall, Casey
    Bupp, Caitrin
    Hutchinson, Amy
    Anderson, James
    Mendez, Kyra
    Spellman, Stephen R.
    Stewart, Valerie
    Savage, Sharon
    Lee, Stephanie J.
    Levine, John
    Saber, Wael
    Aviv, Abraham
    BLOOD, 2023, 142
  • [3] Trial in Progress: A First-in-Human Phase 1/2 Study of Hematopoietic Stem Cell Transplantation (HCT) with VOR33 (CD33-Deleted Allograft) Followed By Treatment with Gemtuzumab Ozogamicin (GO) in Patients with CD33+Acute Myeloid Leukemia (AML) Who Are at High-Risk of Post-HCT Relapse
    Cooper, Brenda W.
    Suh, Hyung C.
    Koura, Divya
    Koehne, Guenther
    Cho, Christina
    Bambace, Nadia M.
    Bernard, Lea
    Shah, Nirali N.
    Walter, Roland B.
    DiPersio, John F.
    Nath, Sritama
    Lee-Sundlov, Melissa M.
    Lacy, Ali
    Stanizzi, Darren
    Kuhn, Karen
    Whangbo, Jennifer S.
    Slapak, Christopher
    Raffel, Glen D.
    BLOOD, 2022, 140 : 12973 - 12975
  • [4] Graft-Vs-Host Disease (GvHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCy) and Thymoglobulin (ATG) Are More Important Determinants of Cytomegalovirus (CMV) Reactivation after Allogeneic Hematopoietic Cell Transplantation (HCT) Than Ex-Vivo T-Cell Depletion in the Era of Pre-Emptive Therapy
    Chong, Lip Leong
    Chia, Chelsea
    Koh, Yin Teng
    Boo, Yang Liang
    Lee, Chun Tsu
    Poon, Michelle
    Tan, Lip Kun
    Koh, Liang Piu
    BLOOD, 2021, 138
1